It's 'either' of those 2 - someone with a bucketload of $$ in the biotech industry could honestly acquire this for the tax loss, and by continuing the same activity field could effectively make $80m tax free, imo.
Unlikely to happen though. Tax losses are great. A company with a history, not always so much..
